This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Disseminating Public Health Evidence to Support Prevention and Control of Diabetes Among Local Health Departments

This study is currently recruiting participants.
See Contacts and Locations
Verified July 2017 by Washington University School of Medicine
Sponsor:
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT03211832
First received: July 6, 2017
Last updated: July 10, 2017
Last verified: July 2017
  Purpose
The purpose of this study is to identify and evaluate dissemination strategies to support the uptake of evidence-based programs and policies (EBPPs) for diabetes prevention and control among local-level public health practitioners. Dissemination strategies such as multi-day in-person training workshops, electronic information exchange modalities, and remote technical assistance are hypothesized to associate with improved access and use of public health evidence and organizational supports for program and policy decision making based on evidence-based public health.

Condition Intervention
Diabetes Chronic Disease Pathologic Processes Disease Attributes Other: Dissemination of public health knowledge

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: No masking
Primary Purpose: Other
Official Title: Enhancing Evidence-based Diabetes Control Among Local Health Departments

Further study details as provided by Washington University School of Medicine:

Primary Outcome Measures:
  • Evidence-based decision making (EBDM) competencies [ Time Frame: 24 months post baseline ]
    Self-report Likert scale items measure perceived importance and availability of specific public health practitioner skill sets for EBDM.

  • Awareness of EBDM [ Time Frame: 24 months post baseline ]
    Self-report Likert scale item measures personal awareness of opportunities to learn about EBDM among local level chronic disease control public health practitioners.

  • Use of EBDM [ Time Frame: 24 months post baseline ]
    Self-report Likert scale items measure personal use of EBDM among local level chronic disease control public health practitioners.

  • Supervisory Support and Expectations for EBDM use [ Time Frame: 24 months post baseline ]
    Self-report Likert scale items measure perceived direct supervisory support, value, and expectations for EBDM use by employees.

  • Work group evaluation maintenance [ Time Frame: 24 months post baseline ]
    Self-report Likert scale of work units' support of community needs assessment, utilization of evaluation for pre and post program implementation use as well as for dissemination purposes.

  • Work group EBDM resources maintenance [ Time Frame: 24 months post baseline ]
    Self-report Likert scale items measure perceived work unit's current skill capacity for EBDM as well as the availability of training and electronic resources to employees for EBDM.

  • Work group climate for EBDM [ Time Frame: 24 months post baseline ]
    Self-report Likert scale items measure work group's perceived level of incorporation of employee and partner informational feedback into decision making.

  • Agency Leadership [ Time Frame: 24 months post baseline ]
    Self-report Likert scale items measure agency leadership support for EBDM.

  • Agency Relationships and Partnerships [ Time Frame: 24 months post baseline ]
    Self-report Likert scale items measure the importance of the type of agency partnerships and support they provide.


Secondary Outcome Measures:
  • Intra- and inter-organization communication around evidence-based programs and policies (EBPPs) [ Time Frame: 24 months post baseline ]
    Self-report social network questionnaire with items that capture other agency work groups and community agencies in which the chronic disease work group has contact, and measures the extent of the contact and how the current relationship is described.


Estimated Enrollment: 240
Actual Study Start Date: July 5, 2017
Estimated Study Completion Date: June 2021
Estimated Primary Completion Date: June 2021 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
The control group will conduct usual public health practice.
Active Comparator: Intervention
Participating local health departments will help develop and choose several dissemination activities they prefer for their local health department to receive. Dissemination activities may include multi-day in-person training workshops, electronic information exchange modalities, remote technical assistance, and information on ways to enhance organizational climates favorable to evidence-based diabetes and chronic disease prevention and control.
Other: Dissemination of public health knowledge
Participating local health departments will help develop and choose dissemination strategies they prefer for their staff working in and supporting diabetes and chronic disease prevention and control to receive. Dissemination strategies may include multi-day in-person training workshops, electronic information exchange modalities, remote technical assistance, and information on ways to enhance organizational climates favorable to evidence-based diabetes prevention and control.

Detailed Description:
Evidence-based public health approaches to prevent and control diabetes and other chronic diseases have been identified in recent decades, and could have a profound effect on diabetes incidence and quality and length of life of those diagnosed. However, barriers to implement approaches continue because of lack of organizational support, limited resources, competing priorities, and limited skill among the public health workforce. The purpose of this study is to determine effective ways to promote the adoption of evidence based public health practice related to diabetes and chronic disease prevention and control among local health departments (LHDs). This stepped-wedge cluster randomized trial aims to evaluate active dissemination strategies on local-level public health practitioners to increase adoption and use of evidence-based programs and policies for diabetes and chronic disease prevention and control among LHDs in Missouri. Twelve LHDs will be recruited and randomly assigned to one of three groups that cross over from usual practice to receive the intervention (dissemination) strategies at 8-month intervals; the intervention duration for groups ranges from 8 to 24 months. LHD staff and the university-based study team are jointly identifying, refining and selecting dissemination strategies. Intervention strategies may include multi-day in-person training workshops, electronic information exchange modalities, and remote technical assistance. Evaluation methods include surveys at baseline and at each 8-month interval, abstraction of LHD chronic disease prevention program plans and progress reports, and social network analysis.
  Eligibility

Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Local Health Departments (LHDs, cluster) in the state of Missouri and corresponding public health workforce (individuals within cluster); screenings.

Exclusion Criteria:

  • LHDs that have less than 5 employees working in or supporting diabetes or chronic disease control, which includes program areas of diabetes prevention and management, obesity prevention, physical activity, nutrition, cardiovascular health, and cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT03211832

Contacts
Contact: Renee Parks, MS 314-935-0148 renee.parks@wustl.edu

Locations
United States, Missouri
Prevention Research Center, Brown School, Washington University in St. Louis Recruiting
Saint Louis, Missouri, United States, 63130
Contact: Renee G Parks, MS    314-935-0148    renee.parks@wustl.edu   
Principal Investigator: Ross C Brownson, PhD         
Sponsors and Collaborators
Washington University School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
Principal Investigator: Ross C Brownson, PhD Prevention Research Center in St. Louis, Brown School, Washington University in St. Louis, Division of Public Health Sciences, Department of Surgery and Alvin J. Siteman Cancer Center, Washington University School of Medicine
  More Information

Additional Information:
Responsible Party: Washington University School of Medicine
ClinicalTrials.gov Identifier: NCT03211832     History of Changes
Other Study ID Numbers: 201705026
5R01DK109913-02 ( U.S. NIH Grant/Contract )
Study First Received: July 6, 2017
Last Updated: July 10, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Washington University School of Medicine:
Dissemination research
Public health workforce
Diabetes prevention
Diabetes control
Chronic disease prevention
Evidence-based public health
Public health accreditation

Additional relevant MeSH terms:
Diabetes Mellitus
Chronic Disease
Pathologic Processes
Disease Attributes
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on July 24, 2017